Trends over time in COPD treatment choices by respiratory physicians: An analysis from the COLIBRI-COPD French cohort

Respiratory Medicine
Nicolas RocheCOLIBRI collaborators

Abstract

Over the last decade, new evidence and many guidelines have been published on COPD pharmacological treatments; prescriptions are often not in accordance with guidelines. Trends in physician treatment choices from February 2012 to November 2018 (Feb.2012/Nov.2018) were analyzed using data from COPD patients (spirometry-confirmed diagnosis) included in the COLIBRI-COPD cohort. Inhaled drug treatments (short- or long-acting β2-agonist [SABA or LABA], short- or long-acting anticholinergic [SAMA or LAMA], or corticosteroid [ICS]) were classified into 5 treatment categories: "No initial maintenance treatment (IMT)" (untreated, or only SAMA or SABA); "1 long-acting bronchodilator (LABD)" (LABA or LAMA); "2 LABDs" (LABA + LAMA); "1 LABD + ICS" (LABA or LAMA + ICS); "2 LABDs + ICS" (LABA + LAMA + ICS). For the purpose of the study, 4 periods were defined to achieve balanced samples (T1-T4). Data from 4537 patients were collected. Over time, 3 major changes were observed: (1) an increase in treatment category "No IMT", mostly for GOLD 1 or GOLD A categories (GOLD A: from 19.1% at T1 to 41.2% at T4); (2) an increase in treatment category "2 LABDs" for GOLD 2 to 4 and GOLD A to D categories (GOLD B: from 15.4% to 29.7%); (3) a decrease in ...Continue Reading

References

Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Oct 7, 2008·The New England Journal of Medicine·Donald P TashkinUNKNOWN UPLIFT Study Investigators
Feb 27, 2010·The European Respiratory Journal·T TroostersUNKNOWN Uplift Investigators
Mar 25, 2011·The New England Journal of Medicine·Claus VogelmeierUNKNOWN POET-COPD Investigators
Jun 1, 2013·The European Respiratory Journal·Eric D BatemanDonald Banerji
Nov 2, 2013·The European Respiratory Journal·Pierre-Régis BurgelUNKNOWN Initiatives BPCO scientific committee
Feb 21, 2014·American Journal of Respiratory and Critical Care Medicine·Jørgen VestboUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Study Investigators
Mar 13, 2014·The Cochrane Database of Systematic Reviews·Kayleigh M Kew, Alieksei Seniukovich
Jul 6, 2014·NPJ Primary Care Respiratory Medicine·Gareth D JamesIrwin Nazareth
Jan 23, 2016·The European Respiratory Journal·Marc MiravitllesFrancesco Blasi
Feb 2, 2016·The European Respiratory Journal·Alvar AgustiIan D Pavord
May 18, 2016·The New England Journal of Medicine·Jadwiga A WedzichaUNKNOWN FLAME Investigators
Apr 1, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Gustavo J RodrigoKonstantinos Kostikas
Apr 5, 2017·American Journal of Respiratory and Critical Care Medicine·David A LipsonSteven J Pascoe
Jul 12, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Syed Mohammad Tariq, Enson C Thomas
Sep 28, 2017·Respiratory Medicine·Heinrich WorthClaus F Vogelmeier
Apr 19, 2018·The New England Journal of Medicine·David A LipsonUNKNOWN IMPACT Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.